Impact of Somatic Mutations on Treatment Response and Resistance in Chronic Myeloid Leukemia
{{output}}
Introduction: Tyrosine kinase inhibitors (TKIs) have transformed the treatment of chronic myeloid leukemia (CML); yet, diverse molecular responses and resistance persist. BCR::ABL1 kinase-domain (TKD) mutations constitute just a ... ...